Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Insight: Pills, TikTok, weight-loss apps and the consumer-driven future of GLP-1s - 2A Manual for Well known Western television Series
- 3Opening Achievement: 8 Methodologies for Compelling Using time productively
- 4Who is Adm. Frank 'Mitch' Bradley and what does he have to do with the Venezuela boat strikes?
- 5Born under fire: MDA delivers baby in Jerusalem minutes before rushing to shelter
- U.S. to drop childhood vaccine recommendations as it looks to Denmark, Washington Post reports
- 5 Side interests That Work on Psychological wellness
- When does Spotify Wrapped come out? The music streamer says 'soon.'
- EU delegation urges China to tighten export controls
- South Africa pushes for $200B investment
- 6 Eyewear Brands Worth Purchasing
- ICAS calls for clearer safeguards in FRC’s TCA policy
- NASA’s history-making moon mission aims to send the first woman and person of color to deep space
- Europe’s EV Boom Was Real in 2025. The Real Fight Starts In 2026
